from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1756c/-

LFCtreatmentdescriptionclass of inhibitor

0.197

Amikacinug/mL Amikacintranslation

0.021

Cap5-10ug/mL Capreomycintranslation

0.145

Rox10-50 ug/mL Roxithromycintranslation

-0.491

SM2-5 ug/mL Streptomycintranslation

-0.953

Tet5-10 ug/mL Tetracyclinetranslation

0.117

Rif0.2-5ug/mL Rifampicintranscription

0.158

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.236

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.549

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.582

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.293

Clofazimine10-13 ug/mL Clofaziminerespiration

0.202

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.596

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.773

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.197

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.215

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.534

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.885

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.253

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.054

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.522

KCN5-20 ug/mL Potassium cyaniderespiration

0.398

NaN30.2-2 mM Sodium aziderespiration

-0.032

Nigericin50 uM Nigericinrespiration

0.288

TRC10-150 ug/mL Triclosanrespiration

-0.398

TRZ10-25 ug/mL Thioridazinerespiration

1.649

Valinomycin0.5-10 uM Valinomycinrespiration

0.694

ZnSO42 mM ZnSO4respiration

-0.309

menadione6-10 ug/mL Menadionerespiration

0.007

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.127

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.369

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.097

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.367

NRP_1Non-replicating persistence stage 1dosRassociated

-0.316

Amp0.2mg/mL AmpicillincellWall

-0.733

Cephalexin20-100 ug/mL CephalexincellWall

-0.003

Cerulenin0.32-5 ug/mL CerulenincellWall

0.229

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.169

EMB10-20 ug/mL EthambutolcellWall

0.235

Eta12-40 ug/mL EthionamidecellWall

-0.326

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.449

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.404

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.454

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.338

BZA0.12 mg/mL BenzamidearomaticAmides

-0.254

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.138

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.385

H2O24 mM hydrogen peroxideDNAdamaging

-0.259

Levo10 ug/mL LevofloxacinDNAdamaging

0.404

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.921

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.309

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.252

UVUV-irradiationDNAdamaging

-0.679

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.313

Antimycin12.5-50 ug/mL Antimycin A?

-0.105

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.106

PA_110-50 ug/mL Antitubercular compound PA-1?

1.038

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.415

PA8240.2-2 ug/mL PA-824?

-0.556

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.105

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.279

Verapamil50 uM Verapamil?

-0.028

mercaptoethanol2 mM 2-Mercaptoethanol?

0.283

methoxatin10-20 ug/mL Methoxatin?